ArticleCell death and differentiation2026
Ubiquitination-mediated degradation of NLRX1 drives metabolic vulnerability and accelerates intervertebral disc degeneration.
Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Intervertebral disc degeneration (IVDD) is driven in part by senescence of nucleus pulposus (NP) cells, yet the metabolic defects underlying this process remain incompletely defined. Although NLRX1 has been implicated in mitochondrial quality control, the mechanisms governing its stability and its role in OXPHOS regulation during IVDD remain unclear. Here, we show that oxidative phosphorylation (OXPHOS) progressively declines with increasing IVDD severity and that loss of NLRX1 contributes to this defect by disrupting mitochondrial respiration and redox homeostasis in NP cells. Nlrx1
Identifiers
42778683What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.